If I read it correctly this company has re-named DMT and is moving forward on research to help TBI.
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI - Algernon Pharmaceuticals (OTC:AGNPF)
In this new podcast, TDR Founder Shadd Dales interviewed Algernon Pharmaceuticals (OTC: AGNPF) CEO, Christopher Moreau.
www.benzinga.com